CMR Surgical announced today that it submitted a 510(k) premarket notification to the FDA for its Versius Plus surgical robot ...

Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...

A new robotic-assisted surgery programme at St John's Hospital in Limerick city has broadened patient access to advanced ...

CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...

CMR Surgical, a British company developing the next-generation surgical robotic system and the Nicholson Center, a center of excellence for training, have launched the first U.S.-based training ...